ALS / Neuromuscular Disorders

California Pacific CURRENTS: The online journal of CPMC Research Institute

Amyotrophic Lateral Sclerosis (ALS)

Description: The purpose of this Phase II research study is to determine safety of EPI-589 and its effects on glutathione in ALS

Title:A Phase 2A Safety and Biomarker Study of EPI-589 in Subjects With Amyotrophic Lateral Sclerosis

Investigators

  • Jonathan Katz, MD


Eligibility Requirements

Patients with amyotrophic lateral sclerosis (ALS) also known as Lou Gehrig's disease who have had symptoms for less than 3 years and FVC above 70%

Status

Active and open to enrollment

Contacts

Dallas Forshew, RN, 415-309-5178, Email: ForsheD@cpmcri.org about Study Edison

Neuromuscular Studies

Description: The purpose of this study is to help researchers learn more about the clinical and biological factors that influence the course of GBS, the outcome of patients with GBS, and to find factors that could help diagnose GBS sooner

Title: (IGOS): A Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in GBS

Investigators

  • Jonathan Katz, MD

Eligibility Requirements

Patients with Guillain-Barré Syndrome (GBS) who have not yet received treatment for GBS

Status

Active and open to enrollment

Contacts

Dallas Forshew, RN, 415-309-5178, Email: ForsheD@cpmcri.org about Study IGOS